Individualizing Therapies in Type 2 Diabetes Mellitus Based on Patient Characteristics: What We Know and What We Need to Know
Author(s) -
Robert J. Smith,
David M. Nathan,
Silva Arslanian,
Leif Groop,
Robert A. Rizza,
Jerome I. Rotter
Publication year - 2010
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2009-1966
Subject(s) - glycemic , type 2 diabetes , need to know , medicine , diabetes mellitus , intensive care medicine , type 2 diabetes mellitus , pathogenesis , precision medicine , bioinformatics , endocrinology , biology , pathology , computer science , computer security
Type 2 diabetes is heterogeneous in its clinical features, pathogenesis, and predisposing or causal genetic factors. This report examines what is known and what needs to be learned about the potential to individualize glycemic therapies in type 2 diabetes, based on phenotypes and genotypes.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom